Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness

被引:688
作者
Larsen, Inger Kristin [1 ]
Smastuen, Milada [1 ]
Johannesen, Tom Borge [1 ]
Langmark, Froydis [1 ]
Parkin, Donald Maxwell [3 ,4 ,5 ]
Bray, Freddie [1 ,2 ]
Moller, Bjorn [1 ]
机构
[1] Canc Registry Norway, Inst Populat Based Canc Res, Dept Clin & Registry Based Res, N-0304 Oslo, Norway
[2] Univ Oslo, Inst Basic Med Sci, Dept Biostat, N-0316 Oslo, Norway
[3] Univ Oxford, Clin Trial Serv Unit, Oxford, England
[4] Univ Oxford, Epidemiol Studies Unit, Oxford, England
[5] Ctr Epidemiol Math & Stat, Canc Res UK, London, England
关键词
Data quality; Cancer Registry; Neoplasms; Comparability; Completeness; Validity; Accuracy; Timeliness; ACCURACY; SURVIVAL; OVARIAN;
D O I
10.1016/j.ejca.2008.10.037
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Aim: To provide a comprehensive evaluation of the quality of the data collected on both solid and non-solid tumours at the Cancer Registry of Norway (CRN). Methods: Established quantitative and semi-quantitative methods were used to assess comparability, completeness, accuracy and timeliness of data for the period 1953-2005, with special attention to the registration period 2001-2005. Results: The CRN coding and classification system by and large follows international standards, with some further subdivisions of morphology groupings performed in-house. The overall completeness was estimated at 98.8% for the registration period 2001-2005. There remains a variable degree of under-reporting particularly for haematological malignancies (C90-95) and tumours of the central nervous system (C70-72). For the same period, 93.8% of the cases were morphologically verified (site-specific range: 60.0-99.8%). The under-reporting in 2005 due to timely publication is estimated at 2.2% overall, based on the number of cases received at the registry during the following year. Conclusion: This review suggests the routines in place at the CRN yields comparable data that can be considered reasonably accurate, close-to-complete and timely, thereby justifying our policy of the reporting of annual incidence one year after the year of diagnosis. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1218 / 1231
页数:14
相关论文
共 37 条
[1]
AASBRENN M, TIDSSKR NOR IN PRESS
[2]
[Anonymous], 1957, MAN INT STAT CLASS D
[3]
[Anonymous], 1948, MAN INT STAT CLASS D
[4]
Adjustment of incidence rates after an estimate of completeness and accuracy in registration of acute leukemias in a Swedish population [J].
Åström, M ;
Bodin, L ;
Tidefelt, U .
LEUKEMIA & LYMPHOMA, 2001, 41 (5-6) :559-570
[5]
BARLOW L, 2008, ACTA ONCOL, P1
[6]
Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability, validity and timeliness [J].
Bray, Freddie ;
Parkin, D. Max .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (05) :747-755
[8]
Curado M.P., 2007, Cancer Incidence in Five Countries, V9, P160
[9]
de Rijke JM, 2000, CANCER, V89, P1121, DOI 10.1002/1097-0142(20000901)89:5<1121::AID-CNCR22>3.0.CO
[10]
2-G